Details of the Drug Reposition

General Information of This Drug (ID: DM8EAGV)

Drug Name	Anti-EGFR V III CAR-T cells DM8EAGV
Drug Type	CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

3 Phase 1/2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Glioma	DIS5RPEH	2A00.0	Phase 1/2	[1]
Hepatocellular carcinoma	DIS0J828	2C12.02	Phase 1/2	[1]
Lung cancer	DISCM4YA	2C25.0	Phase 1/2	[1]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT03638206) Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies